
Total Debt
$82.1K
Net Debt
-$309.4M
Bright Minds Biosciences Inc. currently has $82.1K in total debt. Net debt is -$309.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
DRUG β’ Quarterly Data β’ 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.31 | -0.31Net Cash | 0.31 | 0.0% |
| 2025-12-31 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.1% |
| 2025-09-30 | 0.00 | 0.08 | -0.08Net Cash | 0.08 | 0.1% |
| 2025-06-30 | 0.00 | 0.05 | -0.05Net Cash | 0.05 | 0.3% |
| 2025-03-31 | 0.00 | 0.06 | -0.06Net Cash | 0.06 | 0.3% |
| 2024-12-31 | 0.00 | 0.06 | -0.06Net Cash | 0.06 | 0.3% |
| 2024-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.9% |
| 2024-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.2% |
| 2024-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.5% |
| 2023-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.8% |
| 2023-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.1% |
| 2023-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.1% |
| 2023-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.1% |
| 2022-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.1% |
| 2022-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.2% |
| 2022-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2022-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2021-12-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2021-09-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2021-06-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2021-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2020-12-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2020-09-30 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2019-12-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | β |